Who owns ABIOMED?

Key details on ABIOMED (Ticker: ABMD)

Who owns ABIOMED?

Is ABMD a good stock to own? Find out who bought ABIOMED, who sold ABIOMED (ABMD) stock, and who holds a large position in ABIOMED.

Fund Name Number of Shares Share Valuation As Of
PRIMECAP Management Company 5.66M $140.66M Sept. 30, 2014
Jackson Square Partners 4.75M $117.89M Sept. 30, 2014
Macquarie 3.50M $87.91M June 30, 2014
Essex Woodlands Health Ventures 3.15M $79.19M June 30, 2014
Wellington Management Company 2.57M $64.50M June 30, 2014
Vanguard 2.46M $61.12M Sept. 30, 2014
Palo Alto Investors 2.43M $60.33M Sept. 30, 2014
William Blair $ Company 2.42M $60.07M Sept. 30, 2014
BlackRock Fund Advisors 1.99M $49.38M Sept. 30, 2014
Tiger Global Management 1.69M $41.96M Sept. 30, 2014
Blue Mountain Capital Management 1.61M $41.87M March 31, 2014
Next Century Growth Investors 1.17M $29.16M Sept. 30, 2014
Millennium Management 1.14M $28.31M Sept. 30, 2014
Cortina Asset Management 1.06M $26.43M Sept. 30, 2014
BlackRock Institutional Trust Company, N.A. 1.05M $26.06M Sept. 30, 2014
Royal Bank of Canada 1.00M $24.91M Sept. 30, 2014
Allianz Global Investors of America 903050 $20.04M March 31, 2012
CR Intrinsic Investors 800000 $14.94M March 31, 2013
STATE STREET CORPORATION 727664 $18.07M Sept. 30, 2014
OMT Capital Management 715610 $13.36M March 31, 2013
Arbor Capital Management 712300 $13.16M Dec. 31, 2011
Geneva Capital Management 678016 $17.05M June 30, 2014

Who sold ABIOMED?

Fund Name Date Sold Number of Shares Sold Share Valuation
Columbus Circle Investors June 30, 2011 943204 $15.28M
Norges Bank Investment Management March 31, 2011 1.17M $17.02M
Portolan Capital Management March 31, 2011 1.10M $15.92M